The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
Sethi, S., & Murphy, T. F. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800353 · Cited by 1,234
Azithromycin for prevention of exacerbations of COPD
Albert, R. K., Connett, J., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. K., Lazarus, S. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104623 · Cited by 1,226
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0597oc · Cited by 1,094
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.168.7.818 · Cited by 911
Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD
Wedzicha, J. A., Banerji, D., Chapman, K. R., Vestbo, J., Roche, N., Ayers, R. T., Thach, C., Fogel, R., Patalano, F., & Vogelmeier, C. F. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516385 · Cited by 844
Pascoe, S., Locantore, N., Dransfield, M. T., Barnes, N. C., & Pavord, I. D. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00106-x · Cited by 743
Decramer, M., Rutten-van Mölken, M., Dekhuijzen, P. R., Troosters, T., van Herwaarden, C., Pellegrino, R., van Schayck, C. O., Olivieri, D., Del Donno, M., De Backer, W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66456-2 · Cited by 684
Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD
Vogelmeier, C., Hederer, B., Glaab, T., Schmidt, H., Rutten-van Mölken, M. P. M. H., Beeh, K. M., Rabe, K. F., & Fabbri, L. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008378 · Cited by 684
Aaron, S. D., Vandemheen, K. L., Fergusson, D., Maltais, F., Bourbeau, J., Goldstein, R., Balter, M., O'Donnell, D., McIvor, A., Sharma, S., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00152 · Cited by 649
Fabbri, L. M., Calverley, P. M., Izquierdo-Alonso, J. L., Bundschuh, D. S., Brose, M., Martinez, F. J., & Rabe, K. F. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61252-6 · Cited by 614
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
Magnussen, H., Disse, B., Rodriguez-Roisin, R., Kirsten, A., Watz, H., Tetzlaff, K., Towse, L., Finnigan, H., Dahl, R., Decramer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407154 · Cited by 606
Wedzicha, J. A., Decramer, M., Ficker, J. H., Niewoehner, D. E., Sandström, T., Taylor, A. F., D'Andrea, P., Arrasate, C., Chen, H., & Banerji, D. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70052-3 · Cited by 535
Tiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma
Peters, S. P., Kunselman, S. J., Icitovic, N., Moore, W. C., Pascual, R., Ameredes, B. T., Boushey, H. A., Calhoun, W. J., Castro, M., Cherniack, R. M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008770 · Cited by 519
Chapman, K. R., Burdon, J. G. W., Piitulainen, E., Sandhaus, R. A., Seersholm, N., Stocks, J. M., Stoel, B. C., Huang, L., Yao, Z., Edelman, J. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60860-1 · Cited by 514
Han, M. K., Kazerooni, E. A., Lynch, D. A., Liu, L. X., Murray, S., Curtis, J. L., Criner, G. J., Kim, V., Bowler, R. P., Hanania, N. A., et al. (2011) · Radiology · doi:10.1148/radiol.11110173 · Cited by 453
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial
Siva, R., Green, R. H., Brightling, C. E., Shelley, M., Hargadon, B., McKenna, S., Monteiro, W., Berry, M., Parker, D., Wardlaw, A. J., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00146306 · Cited by 453
Seemungal, T. A. R., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Sapsford, R. J., & Wedzicha, J. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-145oc · Cited by 444
Brusasco, V (2005) · Thorax · doi:10.1136/thx.2005.brusascolett · Cited by 431
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation
The Long-Term Oxygen Treatment Trial Research Group (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604344 · Cited by 428
Singh, D., Papi, A., Corradi, M., Pavlišová, I., Montagna, I., Francisco, C., Cohuet, G., Vezzoli, S., Scuri, M., & Vestbo, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31354-x · Cited by 425
Siddiqui, S. H., Guasconi, A., Vestbo, J., Jones, P., Agusti, A., Paggiaro, P., Wedzicha, J. A., & Singh, D. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0235le · Cited by 415
Brusasco, V (2003) · Thorax · doi:10.1136/thorax.58.5.399 · Cited by 409
Welte, T., Miravitlles, M., Hernandez, P., Eriksson, G., Peterson, S., Polanowski, T., & Kessler, R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200904-0492oc · Cited by 408
Self-citationInhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
Kew, K. M., & Seniukovich, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010115.pub2 · Cited by 398
Martinez, F. J., Calverley, P. M. A., Goehring, U.-M., Brose, M., Fabbri, L. M., & Rabe, K. F. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62410-7 · Cited by 374
Zheng, J.-P., Kang, J., Huang, S.-G., Chen, P., Yao, W.-Z., Yang, L., Bai, C.-X., Wang, C.-Z., Wang, C., Chen, B.-Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60869-7 · Cited by 358
Martínez-García, M.-A., de la Rosa Carrillo, D., Soler-Cataluña, J.-J., Donat-Sanz, Y., Serra, P. C., Lerma, M. A., Ballestín, J., Sánchez, I. V., Selma Ferrer, M. J., Dalfo, A. R., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1518oc · Cited by 340
Self-citationBlood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
Pavord, I. D., Lettis, S., Locantore, N., Pascoe, S., Jones, P. W., Wedzicha, J. A., & Barnes, N. C. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207021 · Cited by 327
Severe exacerbations and BODE index: Two independent risk factors for death in male COPD patients
Soler-Cataluña, J. J., Martínez-García, M. Á., Sánchez, L. S., Tordera, M. P., & Sánchez, P. R. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.12.005 · Cited by 309
Self-citationVogelmeier, C. F., Criner, G. J., Martínez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2017.02.001 · Cited by 309
van der Valk, P., Monninkhof, E., van der Palen, J., Zielhuis, G., & van Herwaarden, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-512oc · Cited by 298
Uzun, S., Djamin, R. S., Kluytmans, J. A. J. W., Mulder, P. G. H., van't Veer, N. E., Ermens, A. A. M., Pelle, A. J., Hoogsteden, H. C., Aerts, J. G. J. V., & van der Eerden, M. M. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70019-0 · Cited by 293
Decramer, M. L., Chapman, K. R., Dahl, R., Frith, P., Devouassoux, G., Fritscher, C., Cameron, R., Shoaib, M., Lawrence, D., Young, D., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70158-9 · Cited by 277
Nannini, L. J., Poole, P., Milan, S. J., Holmes, R., & Normansell, R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003794.pub4 · Cited by 274
An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)
Boyd, G., Morice, A., Pounsford, J., Siebert, M., Peslis, N., & Crawford, C. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10040815 · Cited by 269
Factors Associated With Bronchiectasis in Patients With COPD
Martínez-García, M. Á., Soler-Cataluña, J. J., Donat Sanz, Y., Catalán Serra, P., Agramunt Lerma, M., Ballestín Vicente, J., & Perpiñá-Tordera, M. (2011) · Chest · doi:10.1378/chest.10-1758 · Cited by 267
Self-citationNannini, L. J., Lasserson, T. J., & Poole, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006829.pub2 · Cited by 264
Zheng, J.-P., Wen, F.-Q., Bai, C.-X., Wan, H.-Y., Kang, J., Chen, P., Yao, W.-Z., Ma, L.-J., Li, X., Raiteri, L., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70286-8 · Cited by 258
Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
Miravitlles, M., Soler-Cataluña, J. J., Calle, M., Molina, J., Almagro, P., Quintano, J. A., Riesco, J. A., Trigueros, J. A., Piñera, P., Simón, A., et al. (2012) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2012.04.001 · Cited by 257
Self-citationCalzetta, L., Rogliani, P., Matera, M. G., & Cazzola, M. (2016) · Chest · doi:10.1016/j.chest.2016.02.646 · Cited by 249
Spirometric Criteria for Airway Obstruction
Hansen, J. E., Sun, X.-G., & Wasserman, K. (2007) · Chest · doi:10.1378/chest.06-1349 · Cited by 239
Diagnóstico y tratamiento de las bronquiectasias
Vendrell, M., de Gracia, J., Olveira, C., Ángel Martínez, M., Girón, R., Máiz, L., Cantón, R., Coll, R., Escribano, A., & Solé, A. (2008) · Archivos de Bronconeumología · doi:10.1157/13128330 · Cited by 213
The Role of Long-Acting Bronchodilators in the Management of Stable COPD
Tashkin, D. P., & Cooper, C. B. (2004) · Chest · doi:10.1378/chest.125.1.249 · Cited by 210
Task Force of GesEPOC Grupo de Trabajo de GesEPOC (2012) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(12)70035-2 · Cited by 209
the PULSE Study group, Sethi, S., Jones, P. W., Theron, M. S., Miravitlles, M., Rubinstein, E., Wedzicha, J. A., & Wilson, R. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-10 · Cited by 188
Self-citationPavord, I. D., Lettis, S., Anzueto, A., & Barnes, N. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30148-5 · Cited by 184
Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD
Miravitlles, M., Soler-Cataluña, J. J., Calle, M., Molina, J., Almagro, P., Quintano, J. A., Riesco, J. A., Trigueros, J. A., Piñera, P., Simón, A., et al. (2012) · Archivos de Bronconeumología (English Edition) · doi:10.1016/j.arbr.2012.05.003 · Cited by 167
Self-citationSoriano, J. B., Lamprecht, B., Ramírez, A. S., Martinez-Camblor, P., Kaiser, B., Alfageme, I., Almagro, P., Casanova, C., Esteban, C., Soler-Cataluña, J. J., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00157-5 · Cited by 162
Self-citationBarrecheguren, M., Esquinas, C., & Miravitlles, M. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000118 · Cited by 160
Self-citationOxygen Therapy in Chronic Obstructive Pulmonary Disease
Kim, V., Benditt, J. O., Wise, R. A., & Sharafkhaneh, A. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200708-124et · Cited by 158
Aalbers, R., Ayres, J. G., Backer, V., Decramer, M., Lier, P. A., Magyar, P., Małolepszy, J., Ruffin, R. E., & Sybrecht, G. W. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00240902 · Cited by 153
Koblížek, V., Chlumský, J., Zindr, V., Neumannová, K., Zatloukal, J., Žák, J., Sedlák, V., Kocianova, J., Zatloukal, J., Hejduk, K., et al. (2013) · Biomedical Papers · doi:10.5507/bp.2013.039 · Cited by 151
Kankaanranta, H., Harju, T. H., Kilpeläinen, M., Mazur, W., Lehto, J. T., Katajisto, M., Peisa, T., Meinander, T., & Lehtimäki, L. A. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12366 · Cited by 131
Martínez, F. J., Rabe, K. F., Sethi, S., Pizzichini, E., McIvor, A., Anzueto, A., Alagappan, V. K. T., Siddiqui, S. S., Rekeda, L., Miller, C. J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1349oc · Cited by 130
Rossi, A., Guerriero, M., & Corrado, A. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-77 · Cited by 127
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD
Rossi, A., van der Molen, T., del Olmo, R., Papi, A. A., Wehbe, L., Quinn, M., Lu, C., Young, D., Cameron, R., Bucchioni, E., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00126814 · Cited by 126
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history
Bateman, E. D., Rabe, K. F., Calverley, P. M. A., Goehring, U.-M., Brose, M., Bredenbröker, D., & Fabbri, L. M. (2011) · European Respiratory Journal · doi:10.1183/09031936.00178710 · Cited by 120
Oba, Y., Sarva, S. T., & Dias, S. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206732 · Cited by 120
Ni, W., Shao, X., Cai, X., Wei, C., Cui, J., Wang, R., & Liu, Y.-N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121257 · Cited by 115
Puhan, M. A., Bachmann, L. M., Kleijnen, J., ter Riet, G., & Kessels, A. G. H. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-2 · Cited by 108
Barreiro, E., Bustamante, V., Cejudo, P., Gáldiz, J. B., Gea, J., de Lucas, P., Martínez‐Llorens, J., Ruiz, F. Ó., Puente‐Maestu, L., Roca, J., et al. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2015.04.011 · Cited by 106
Short-acting beta2-agonists for stable chronic obstructive pulmonary disease
Sestini, P., Renzoni, E. A., Robinson, S. M., Poole, P., & Ram, F. S. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001495 · Cited by 103
Bradley, J. M., Lasserson, T., Elborn, S., MacMahon, J., & O'Neill, B. (2007) · Chest · doi:10.1378/chest.06-0180 · Cited by 101
Frith, P. A., Thompson, P. J., Ratnavadivel, R., Chang, C. L., Bremner, P. R., Day, P., Frenzel, C., Kurstjens, N., & the Glisten Study Group (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206670 · Cited by 89
Variability and effects of bronchial colonisation in patients with moderate COPD
Marín, A., Monsó, E., García-Núñez, M., Sauleda, J., Noguera, A., Pons, J., Agustí, A. G. N., & Morera, J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00126808 · Cited by 86
Nadeem, N. J., Taylor, S. J., & Eldridge, S. M. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-107 · Cited by 85
Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease
Finney, L., Berry, M. P. R., Singanayagam, A., Elkin, S., Johnston, S. L., & Mallia, P. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70169-9 · Cited by 84
Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach
Stockley, R. A., Miravitlles, M., Vogelmeier, C. F., & Behalf of Alpha One International Registry (A.I.R.) (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-149 · Cited by 83
Self-citationLong-term azithromycin therapy in patients with severe COPD and repeated exacerbations
Pomares, X., Montón, C., Espasa, M., Salas, J. C., Monsó, E., & Gallego, M. (2011) · International Journal of COPD · doi:10.2147/copd.s23655 · Cited by 78
Maldonado, F. C., Blanco, I., Martínez, M. T., Bustamante, A., Miravitlles, M., Cadenas, S., Pérez, J. M. H., Lázaro, L., Rodríguez, E., Rodríguez‐Frias, F., et al. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2014.05.008 · Cited by 77
Self-citationColour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease
Miravitlles, M., Marín, A., Monsó, E., Vila, S. P., de la Roza, C., Hervás, R., Esquinas, C., García-Núñez, M., Millares, L., Morera, J., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-58 · Cited by 76
Self-citationRam, F. S., Jardin, J. R., Atallah, Á. N., Castro, A. A., Mazzini, R., Goldstein, R. S., Lacasse, Y., & Cendon, S. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.10.009 · Cited by 76
Cosío, B. G., Soriano, J. B., López-Campos, J. L., Rubio, M. C., Soler‐Cataluña, J. J., de-Torres, J. P., Marín, J. M., González, C. M., de Lucas, P., Mir, I., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160770 · Cited by 71
Self-citationAdverse Effects of Inhaled Corticosteroids in Funded and Nonfunded Studies
Nieto, A., Mazón, Á., Pamies, R., Liñana, J. J., Lanuza, A., Jiménez, F. O., Medina‐Hernandez, A., & Nieto, F. J. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.19.2047 · Cited by 69
Benefits of High-Dose N-Acetylcysteine to Exacerbation-Prone Patients With COPD
Tse, H. N., Raiteri, L., Wong, K. Y., Ng, L. Y., Yee, K. S., & Tseng, C. Z. S. (2014) · CHEST Journal · doi:10.1378/chest.13-2784 · Cited by 67
Maldonado, F. C., Blanco, I., Martínez, M. T., Bustamante, A., Miravitlles, M., Cadenas, S., Hernández, J. M., Lázaro, L., Rodríguez, E., Rodríguez‐Frias, F., et al. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2014.12.006 · Cited by 65
Self-citationClinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study
Rubio, M. C., Navarrete, B. A., Soriano, J. B., et al. (2017) · International Journal of COPD · doi:10.2147/copd.s124482 · Cited by 65
Self-citationSiler, T. M., Kerwin, E., Singletary, K., Brooks, J., & Church, A. (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1034256 · Cited by 64
Schlueter, M., González-Rojas, N., Baldwin, M., Groenke, L., Voß, F., & Reason, T. (2016) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465815624612 · Cited by 60
Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review
Miravitlles, M., D’Urzo, A. D., Singh, D., & Koblížek, V. (2016) · Respiratory Research · doi:10.1186/s12931-016-0425-5 · Cited by 54
Self-citationStockley, R. A., Whitehead, P. J., & Williams, M. K. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-147 · Cited by 52
Continuous home oxygen therapy.
Ruiz, F. Ó., Lobato, S. D., Iturri, J. B. G., Río, F. G., Rous, R. G., Morante-Vélez, F., Maestú, L. P., & Camarasa, J. T. (2014) · Archivos de Bronconeumologia · doi:10.1016/j.arbres.2013.11.025 · Cited by 50
Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
Santos, S., Marín, A., Serra-Batllés, J., de la Rosa, D., Solanes, I., Pomares, X., López‐Sánchez, M., Muñoz‐Esquerre, M., & Miravitlles, M. (2016) · International Journal of COPD · doi:10.2147/copd.s98333 · Cited by 49
Self-citationAlonso‐Coello, P., Comas, D. R., Sanabria, A. J., Plaza, V., Miravitlles, M., & Martinez, L. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2012.12.001 · Cited by 47
Self-citationNavarrete, B. A., Casanova, C., Miravitlles, M., et al. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2014.11.001 · Cited by 40
Self-citationKarner, C., & Cates, C. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009039.pub2 · Cited by 33
Navarrete, B. A., Casanova, C., Miravitlles, M., et al. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2015.02.002 · Cited by 27
Self-citationLong-acting ß-adrenoceptor agonists in the management of COPD: focus on indacaterol
Beeh, K. M. (2011) · International Journal of COPD · doi:10.2147/copd.s7371 · Cited by 23
Tratamiento del tabaquismo en fumadores con enfermedad pulmonar obstructiva crónica
Jimenez-Ruiz, C. A., Miranda, J. A. R., Gómez, N. A., Blasco, J. J. L., Miñana, J. S.-C., Reina, S. S., Orive, J. I. D. G., Pinedo, Á. R., Muñiz, M. Á. M., & Ferrero, M. B. (2013) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2013.02.005 · Cited by 23
Cited by
Cardiovascular disease and COPD: dangerous liaisons?
Rabe, K. F., Hurst, J. R., & Suissa, S. (2018) · European Respiratory Review · doi:10.1183/16000617.0057-2018 · Cited by 410
Barreiro, E., Puig-Vilanova, E., Salazar-Degracia, A., Pascual-Guardia, S., Casadevall, C., & Gea, J. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00798.2017 · Cited by 30
Metadata
- Authors
- Miravitlles, M., Soler-Cataluña, J. J., Calle, M., Molina, J., Almagro, P., Quintano, J. A., Trigueros, J. A., Cosío, B. G., Casanova, C., Antonio Riesco, J., Simonet, P., Rigau, D., Soriano, J. B., & Ancochea, J.
- Venue
- Archivos de Bronconeumología
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 53
- Issue
- 6
- Pages
- 324-335
- ISSN
- 0300-2896 (ISSN-L)
- OpenAlex
- W2610956233
- Cited by
- 378
- References
- 94
- FWCI
- 54.47
- Type
- journal article
- Language
- es
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.